FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978579402> ?p ?o ?g. }

• W1978579402 endingPage "921" @default.
• W1978579402 startingPage "917" @default.
• W1978579402 abstract "Recently, we reported that the in vivo efficacy of acyclovir (ACV) formulations was a single valued function of skin target site free drug concentration (C) irrespective of the formulation compositions. A long-term objective of this research has been to generalize the C concept using model drugs which are similar to as well as different from ACV in their mechanism of actions. (Bromovinyl)deoxyuridine (BVDU) was selected as a model drug based on the reported similarity in its mechanism of action with ACV. The relationship between the C predictions and the in vivo efficacies for some topical formulations containing different concentrations (0.05-10%) of either ACV or BVDU in 95% DMSO as a vehicle with or without 5% Azone as skin permeation enhancer was examined. Hairless mice infected cutaneously with HSV-1 were used to quantitatively estimate the in vivo topical antiviral efficacy. A finite dose of the test antiviral formulation was applied twice a day for 4 days, starting the day after virus inoculation. On the fifth day, the lesions were scored and the efficacy values were calculated. For each formulation, in vitro flux experiments were performed in an in vivo-in vitro experimental design that closely approximated the in vivo study protocol. As was previously shown, with all ACV formulations, a good correlation was found between the C predictions and the in vivo topical efficacy. With the BVDU formulations, on the other hand, this was found not to be the case. BVDU formulations with 5% Azone were generally much more effective than those without Azone at comparable C values. This finding is believed to be the first of its kind showing that skin permeation enhancers may enhance efficacy by more than simply increasing skin permeation rates." @default.
• W1978579402 created "2016-06-24" @default.
• W1978579402 creator A5000319432 @default.
• W1978579402 creator A5006462643 @default.
• W1978579402 creator A5015242485 @default.
• W1978579402 creator A5029676035 @default.
• W1978579402 creator A5036566256 @default.
• W1978579402 creator A5037624441 @default.
• W1978579402 creator A5040662398 @default.
• W1978579402 date "1998-08-01" @default.
• W1978579402 modified "2023-09-27" @default.
• W1978579402 title "Assessment of Correlation between Skin Target Site Free Drug Concentration and the in Vivo Topical Antiviral Efficacy in Hairless Mice for (E)-5-(2-Bromovinyl)-2′-Deoxyuridine and Acyclovir Formulations" @default.
• W1978579402 cites W1575823897 @default.
• W1978579402 cites W1969012210 @default.
• W1978579402 cites W1970291943 @default.
• W1978579402 cites W1973009383 @default.
• W1978579402 cites W1984444755 @default.
• W1978579402 cites W2014720564 @default.
• W1978579402 cites W2060655987 @default.
• W1978579402 cites W2061655374 @default.
• W1978579402 cites W2064985706 @default.
• W1978579402 cites W2104796719 @default.
• W1978579402 cites W2112886158 @default.
• W1978579402 cites W2139831017 @default.
• W1978579402 cites W2179131832 @default.
• W1978579402 cites W346311905 @default.
• W1978579402 doi "https://doi.org/10.1021/js980052a" @default.
• W1978579402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9687333" @default.
• W1978579402 hasPublicationYear "1998" @default.
• W1978579402 type Work @default.
• W1978579402 sameAs 1978579402 @default.
• W1978579402 citedByCount "14" @default.
• W1978579402 countsByYear W19785794022013 @default.
• W1978579402 countsByYear W19785794022016 @default.
• W1978579402 countsByYear W19785794022017 @default.
• W1978579402 countsByYear W19785794022019 @default.
• W1978579402 countsByYear W19785794022021 @default.
• W1978579402 countsByYear W19785794022022 @default.
• W1978579402 crossrefType "journal-article" @default.
• W1978579402 hasAuthorship W1978579402A5000319432 @default.
• W1978579402 hasAuthorship W1978579402A5006462643 @default.
• W1978579402 hasAuthorship W1978579402A5015242485 @default.
• W1978579402 hasAuthorship W1978579402A5029676035 @default.
• W1978579402 hasAuthorship W1978579402A5036566256 @default.
• W1978579402 hasAuthorship W1978579402A5037624441 @default.
• W1978579402 hasAuthorship W1978579402A5040662398 @default.
• W1978579402 hasConcept C112705442 @default.
• W1978579402 hasConcept C150903083 @default.
• W1978579402 hasConcept C185592680 @default.
• W1978579402 hasConcept C202751555 @default.
• W1978579402 hasConcept C203014093 @default.
• W1978579402 hasConcept C207001950 @default.
• W1978579402 hasConcept C2522874641 @default.
• W1978579402 hasConcept C2776005048 @default.
• W1978579402 hasConcept C2776409557 @default.
• W1978579402 hasConcept C2777111502 @default.
• W1978579402 hasConcept C2779156968 @default.
• W1978579402 hasConcept C2779450786 @default.
• W1978579402 hasConcept C2779756493 @default.
• W1978579402 hasConcept C2780035454 @default.
• W1978579402 hasConcept C2780727368 @default.
• W1978579402 hasConcept C41625074 @default.
• W1978579402 hasConcept C50670333 @default.
• W1978579402 hasConcept C552990157 @default.
• W1978579402 hasConcept C55493867 @default.
• W1978579402 hasConcept C71924100 @default.
• W1978579402 hasConcept C86803240 @default.
• W1978579402 hasConcept C98274493 @default.
• W1978579402 hasConceptScore W1978579402C112705442 @default.
• W1978579402 hasConceptScore W1978579402C150903083 @default.
• W1978579402 hasConceptScore W1978579402C185592680 @default.
• W1978579402 hasConceptScore W1978579402C202751555 @default.
• W1978579402 hasConceptScore W1978579402C203014093 @default.
• W1978579402 hasConceptScore W1978579402C207001950 @default.
• W1978579402 hasConceptScore W1978579402C2522874641 @default.
• W1978579402 hasConceptScore W1978579402C2776005048 @default.
• W1978579402 hasConceptScore W1978579402C2776409557 @default.
• W1978579402 hasConceptScore W1978579402C2777111502 @default.
• W1978579402 hasConceptScore W1978579402C2779156968 @default.
• W1978579402 hasConceptScore W1978579402C2779450786 @default.
• W1978579402 hasConceptScore W1978579402C2779756493 @default.
• W1978579402 hasConceptScore W1978579402C2780035454 @default.
• W1978579402 hasConceptScore W1978579402C2780727368 @default.
• W1978579402 hasConceptScore W1978579402C41625074 @default.
• W1978579402 hasConceptScore W1978579402C50670333 @default.
• W1978579402 hasConceptScore W1978579402C552990157 @default.
• W1978579402 hasConceptScore W1978579402C55493867 @default.
• W1978579402 hasConceptScore W1978579402C71924100 @default.
• W1978579402 hasConceptScore W1978579402C86803240 @default.
• W1978579402 hasConceptScore W1978579402C98274493 @default.
• W1978579402 hasIssue "8" @default.
• W1978579402 hasLocation W19785794021 @default.
• W1978579402 hasLocation W19785794022 @default.
• W1978579402 hasOpenAccess W1978579402 @default.
• W1978579402 hasPrimaryLocation W19785794021 @default.
• W1978579402 hasRelatedWork W1491964893 @default.
• W1978579402 hasRelatedWork W1978579402 @default.
• W1978579402 hasRelatedWork W1980239620 @default.

• next